Quest Diagnostics (DGX) Competitors $178.06 -0.16 (-0.09%) As of 12:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DGX vs. LH, DVA, CHE, CRVL, AMED, MD, AMN, CCRN, NTRA, and EXASShould you be buying Quest Diagnostics stock or one of its competitors? The main competitors of Quest Diagnostics include Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Natera (NTRA), and Exact Sciences (EXAS). Quest Diagnostics vs. Laboratory Co. of America DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Natera Exact Sciences Laboratory Co. of America (NYSE:LH) and Quest Diagnostics (NYSE:DGX) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings, valuation and community ranking. Does the MarketBeat Community favor LH or DGX? Laboratory Co. of America received 83 more outperform votes than Quest Diagnostics when rated by MarketBeat users. Likewise, 63.91% of users gave Laboratory Co. of America an outperform vote while only 49.14% of users gave Quest Diagnostics an outperform vote. CompanyUnderperformOutperformLaboratory Co. of AmericaOutperform Votes62763.91% Underperform Votes35436.09% Quest DiagnosticsOutperform Votes54449.14% Underperform Votes56350.86% Do institutionals & insiders believe in LH or DGX? 95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are held by institutional investors. 0.8% of Laboratory Co. of America shares are held by insiders. Comparatively, 8.2% of Quest Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, LH or DGX? Laboratory Co. of America has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Is LH or DGX more profitable? Quest Diagnostics has a net margin of 8.80% compared to Laboratory Co. of America's net margin of 5.73%. Laboratory Co. of America's return on equity of 15.29% beat Quest Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Laboratory Co. of America5.73% 15.29% 7.01% Quest Diagnostics 8.80%15.07%6.72% Does the media favor LH or DGX? In the previous week, Quest Diagnostics had 8 more articles in the media than Laboratory Co. of America. MarketBeat recorded 37 mentions for Quest Diagnostics and 29 mentions for Laboratory Co. of America. Laboratory Co. of America's average media sentiment score of 1.01 beat Quest Diagnostics' score of 0.72 indicating that Laboratory Co. of America is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Laboratory Co. of America 15 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 17 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Do analysts rate LH or DGX? Laboratory Co. of America currently has a consensus price target of $267.85, indicating a potential upside of 11.20%. Quest Diagnostics has a consensus price target of $185.07, indicating a potential upside of 3.74%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, research analysts clearly believe Laboratory Co. of America is more favorable than Quest Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Laboratory Co. of America 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.87Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69 Is LH or DGX a better dividend stock? Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Quest Diagnostics pays an annual dividend of $3.20 per share and has a dividend yield of 1.8%. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Quest Diagnostics pays out 40.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Quest Diagnostics has increased its dividend for 14 consecutive years. Quest Diagnostics is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has better earnings & valuation, LH or DGX? Quest Diagnostics has lower revenue, but higher earnings than Laboratory Co. of America. Quest Diagnostics is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLaboratory Co. of America$13.01B1.55$746M$8.8227.31Quest Diagnostics$10.16B1.96$871M$7.9122.55 SummaryLaboratory Co. of America beats Quest Diagnostics on 14 of the 22 factors compared between the two stocks. Get Quest Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DGX vs. The Competition Export to ExcelMetricQuest DiagnosticsMedical laboratories IndustryMedical SectorNYSE ExchangeMarket Cap$19.91B$2.88B$5.57B$18.97BDividend Yield1.84%31.29%5.11%4.03%P/E Ratio23.2013.2822.4432.71Price / Sales1.96188.21394.1027.85Price / Cash12.8257.5638.1817.53Price / Book2.924.676.774.47Net Income$871M-$22.21M$3.22B$1.02B7 Day Performance1.40%-1.91%1.48%0.50%1 Month Performance5.28%3.24%3.99%-2.83%1 Year Performance29.69%11.50%16.20%4.36% Quest Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DGXQuest Diagnostics4.5603 of 5 stars$178.06-0.1%$185.07+3.9%+29.1%$19.87B$10.16B23.1549,000Analyst ForecastShort Interest ↑LHLaboratory Co. of America4.7186 of 5 stars$230.45+0.9%$268.77+16.6%+19.6%$19.27B$13.01B26.1175,500Earnings ReportAnalyst ForecastShort Interest ↑DVADaVita4.2789 of 5 stars$140.64+0.8%$166.33+18.3%+1.9%$11.24B$12.82B13.0870,000Positive NewsCHEChemed4.5727 of 5 stars$565.83+1.8%$674.00+19.1%+2.0%$8.25B$2.49B28.5314,200Analyst ForecastPositive NewsCRVLCorVel0.9477 of 5 stars$109.94-0.3%N/A+36.6%$5.65B$871.31M64.694,230News CoveragePositive NewsAMEDAmedisys2.8915 of 5 stars$94.79+0.3%$100.75+6.3%+3.1%$3.11B$2.37B37.5820,000Analyst RevisionMDPediatrix Medical Group2.0428 of 5 stars$12.37+1.0%$16.75+35.4%+45.7%$1.06B$2.01B-10.307,850Upcoming EarningsAMNAMN Healthcare Services4.2509 of 5 stars$19.32+0.7%$38.67+100.2%-65.9%$736.48M$2.98B-5.014,230Upcoming EarningsAnalyst RevisionNews CoverageCCRNCross Country Healthcare3.5268 of 5 stars$13.51-1.8%$18.41+36.3%-23.0%$442.78M$1.34B-270.052,700Analyst ForecastNews CoveragePositive NewsNTRANatera2.8632 of 5 stars$153.16-0.4%$175.76+14.8%+62.5%$20.76B$1.70B-87.253,020Upcoming EarningsInsider TradePositive NewsEXASExact Sciences4.4898 of 5 stars$45.58+0.3%$69.25+51.9%-23.1%$8.47B$2.76B-8.196,400 Related Companies and Tools Related Companies Laboratory Co. of America Alternatives DaVita Alternatives Chemed Alternatives CorVel Alternatives Amedisys Alternatives Pediatrix Medical Group Alternatives AMN Healthcare Services Alternatives Cross Country Healthcare Alternatives Natera Alternatives Exact Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DGX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.